Advertisement
Canada markets close in 2 hours 33 minutes
  • S&P/TSX

    21,837.77
    -35.95 (-0.16%)
     
  • S&P 500

    5,029.50
    -42.13 (-0.83%)
     
  • DOW

    37,996.11
    -464.81 (-1.21%)
     
  • CAD/USD

    0.7311
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    82.59
    -0.22 (-0.27%)
     
  • Bitcoin CAD

    88,139.22
    -692.39 (-0.78%)
     
  • CMC Crypto 200

    1,397.71
    +15.14 (+1.10%)
     
  • GOLD FUTURES

    2,341.60
    +3.20 (+0.14%)
     
  • RUSSELL 2000

    1,973.56
    -21.87 (-1.10%)
     
  • 10-Yr Bond

    4.6980
    +0.0460 (+0.99%)
     
  • NASDAQ

    15,531.85
    -180.90 (-1.15%)
     
  • VOLATILITY

    16.38
    +0.41 (+2.57%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6809
    -0.0010 (-0.15%)
     

COVID-19 treatment Bamlanivimab goes unused

COVID-19 vaccines have come fast but treatments for the disease are still limited. When a Canadian company developed Bamlanivimab, a new monoclonal antibody drug, Ottawa spent millions on doses. But after the rush to buy them they've sat on shelves for months, unused.